title: Adjuvant arthritis and immunity to the mycobacterial 65 kDa heat shock protein.
abstract: The mycobacterial 65 kDa heat shock protein (HSP65) is of critical significance in the model of adjuvant arthritis (AA). Arthritogenic and protective T cell clones obtained from arthritic rats recognized the 180-188 sequence of HSP65. Previous reports have shown that administration of HSP65 prior to disease induction led to resistance to arthritis in the AA model and in several other models of experimental arthritis. Here, we report the development of immunity to HSP65 and the critical 180-188 epitope during the course of AA. Following Mycobacterium tuberculosis (MT) immunization both antibodies and T cell responses to HSP65 were detected. Proliferative responses to the 180-188 epitope were seen exclusively in the local draining lymph node cells at day 14 after immunization. The anatomical distribution and course of T cell responses to HSP65 and its 180-188 epitope are compatible with T cell regulated control of the disease. Although lower HSP65 antibody levels were observed in the animals with severe arthritis, in individual animals no evidence was obtained for a relationship between development of HSP65 humoral immunity and arthritis severity. Nevertheless, during disease exacerbation, elicited by HSP65 immunization during disease development, elevated T cell responses against HSP65 and its 180-188 epitope were found. In contrast, we obtained evidence that successful transfer of arthritis resistance to naive recipients depends on the transfer of HSP65 specific T cells. On the basis of these results, it seems that HSP65 plays a crucial role in the T cell regulatory events involved in both the induction of, and protection against, AA.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Virology, University of Amsterdam, The Netherlands.
authors.forename: E J
authors.initials: EJ
authors.lastname: Hogervorst
authors.forename: J P
authors.initials: JP
authors.lastname: Wagenaar
authors.forename: C J
authors.initials: CJ
authors.lastname: Boog
authors.forename: R
authors.initials: R
authors.lastname: van der Zee
authors.forename: J D
authors.initials: JD
authors.lastname: van Embden
authors.forename: W
authors.initials: W
authors.lastname: van Eden
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D000942:Antigens, Bacterial / Q000008:administration & dosage; D001169:Arthritis, Experimental / Q000209:etiology / Q000276:immunology*; D006360:Heat-Shock Proteins / Q000276:immunology*; D007111:Immunity, Cellular; D007116:Immunization, Passive; D008297:Male; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D051381:Rats; D011917:Rats, Inbred Lew; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D006360:Heat-Shock Proteins